Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc. (Nasdaq: EXPO) is a leading engineering and scientific consulting firm dedicated to providing solutions to complex issues faced by various industries. The company operates through a highly multidisciplinary organization comprising scientists, physicians, engineers, and business consultants, bringing together over 90 technical disciplines. With a presence in 20 offices across the United States and 6 international locations, Exponent is committed to delivering unparalleled technical expertise.
Core Business and Services: Exponent operates through two main segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment, which accounts for the majority of Exponent's revenue, focuses on services such as biomechanics, biomedical engineering, civil engineering, and construction consulting. The Environmental and Health segment addresses chemical regulation, food safety, ecological and biological sciences, and environmental and earth sciences.
Latest Achievements: Exponent recently reported a 5% increase in total revenues for the third quarter of 2023, highlighting its adaptability and diversified portfolio. The company also announced a quarterly cash dividend of $0.26 per share to be paid in December 2023 and has continued its commitment to return value to shareholders through dividends and stock repurchases.
Recent Projects: The firm is actively engaged in failure analysis and dispute-related work across multiple sectors, including consumer electronics, transportation, and energy. It has also been involved in regulatory consulting services for the chemical industry and in providing safety-related evaluations.
Financial Condition: Exponent's financial results for the first three quarters of 2023 include a 7% increase in total revenues to $413.9 million. The company closed the period with $137.1 million in cash and cash equivalents, indicating robust financial health.
Partnerships and Collaborations: Exponent collaborates with a wide range of clients, including multinational corporations, startups, law firms, insurance companies, and government agencies. This diverse client base underscores the firm's ability to address a variety of complex challenges.
In summary, Exponent Inc. continues to leverage its deep technical expertise and multidisciplinary approach to address the evolving needs of modern industries, ensuring long-term growth and value creation for its stakeholders.
Exponent, Inc. (NASDAQ: EXPO) announced the appointment of John Doyle, Dr.P.H., as Group Vice President, Health Sciences on May 17, 2021. Dr. Doyle will lead the company's Health Sciences team, addressing environmental, occupational, medical, and public health challenges. CEO Dr. Catherine Corrigan highlighted Dr. Doyle's experience in healthcare research and the pharmaceutical sector, aiming to drive growth in life sciences. Dr. Doyle has authored over 200 research articles, primarily in oncology, and holds advanced degrees in Epidemiology from Columbia University.
Exponent, Inc. (Nasdaq:EXPO) announced that CEO Dr. Catherine Corrigan and CFO Richard Schlenker will present at the Berenberg Conference USA 2021 on May 18, 2021, at 11:00 AM PT. Investors can access a live webcast of this presentation on Exponent's investor relations website, with an archived replay available afterward. Exponent is known for its engineering and scientific consulting, leveraging over 50 years of experience to tackle complex challenges across various sectors.
Exponent, Inc. (Nasdaq:EXPO) declared a quarterly cash dividend of $0.20 per share, to be paid on June 25, 2021, to stockholders of record as of June 11, 2021. The company has consistently increased dividends, marking the eighth consecutive year of growth, reflecting its strong balance sheet and commitment to long-term shareholder value. Exponent plans to continue quarterly dividends in March, June, September, and December, contingent upon Board approval.
Exponent, Inc. (Nasdaq:EXPO) reported a 10% increase in net revenues for Q1 FY2021, totaling $116.5 million. EBITDA rose to $31.8 million, reflecting a margin improvement of 400 basis points year-over-year. Net income grew to $30.8 million or $0.58 per diluted share. The engineering segment contributed 81% of revenues with an 11% growth, while the environmental segment saw a 7% increase. Exponent anticipates continued growth with Q2 revenue growth projected in the low twenties and full-year guidance in the high-single to low-double digits.
Exponent, Inc. (Nasdaq: EXPO) announced it will report its first quarter fiscal year 2021 financial results on April 29, 2021, after market close. The conference call hosted by CEO Dr. Catherine Corrigan and CFO Richard Schlenker will begin at 4:30 p.m. ET. Shareholders can access the call live or via archived webcast on the company's Investor Relations page. A telephonic replay will also be available until May 6, 2021.
Exponent, Inc. (Nasdaq:EXPO) announced that CEO Dr. Catherine Corrigan and CFO Richard Schlenker will present at the Truist Securities Technology, Internet & Services Summit on March 9, 2021, from 8:20am to 9:00am PT. A webcast of the event will be available on the investor relations section of Exponent's website, where an archived replay will also be provided afterward. Exponent specializes in engineering and scientific consulting, aiding clients in complex challenges through over 50 years of experience.
Dr. Catherine Ford Corrigan was elected to the National Academy of Engineering on February 9, 2021, a significant honor in the field of engineering. She is recognized for her impactful research in injury mechanics and her leadership roles in biomechanical engineering and scientific consulting at Exponent. Over 25 years, Dr. Corrigan has cultivated talent among engineers, scientists, and regulatory experts, thus enhancing the firm's reputation. Paul R. Johnston, Chairman of Exponent, praised her leadership in maintaining scientific excellence.
Exponent, Inc. (Nasdaq:EXPO) announced an increase in its quarterly cash dividend to $0.20 per share, payable on March 26, 2021, to shareholders of record as of March 12, 2021. This decision, highlighted by CEO Dr. Catherine Corrigan, underscores the company’s business resilience and robust balance sheet, signaling a commitment to generating long-term value for shareholders. Exponent aims to maintain quarterly dividends each March, June, September, and December, subject to Board approval.
Exponent, Inc. (Nasdaq: EXPO) reported Q4 and FY 2020 results, revealing a 6% decrease in total revenues to $103.2 million for the quarter and 4% decrease to $399.9 million for the fiscal year. Despite these declines, net income rose to $21.8 million ($0.41/share) in Q4, up from $19.1 million. EBITDA increased to $28.3 million from $27.7 million. For FY 2021, Exponent expects low-single digit revenue growth before reimbursements. The company maintains a strong cash position of $242.5 million and plans to increase its quarterly dividend from $0.19 to $0.20.
Exponent, Inc. (Nasdaq:EXPO) announced it will report its fourth quarter and fiscal year 2020 financial results on February 4, 2021, after market close. The company will host a conference call at 4:30 p.m. ET to discuss the results, featuring CEO Dr. Catherine Corrigan and CFO Richard Schlenker. Interested parties can access the call by phone or via the company's Investor Relations webpage. A telephonic replay will be available until February 11, 2021.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
What services does Exponent Inc. offer?
What are Exponent's main business segments?
How has Exponent performed financially recently?
Where is Exponent Inc. located?
Who are Exponent's clients?
What recent projects has Exponent been involved in?
What recent achievements has Exponent announced?
What is Exponent's approach to problem-solving?
How can I contact Exponent Inc.?
What is Exponent's outlook for the future?
